- Home
- Publications
- Publication Search
- Publication Details
Title
Iron metabolism and iron supplementation in cancer patients
Authors
Keywords
Iron deficiency, Functional and absolute iron deficiency, Tumor anemia, Iron supplementation, Recommendations for clinical practice
Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume 127, Issue 23-24, Pages 907-919
Publisher
Springer Nature
Online
2015-09-15
DOI
10.1007/s00508-015-0842-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe2+?
- (2017) Jeffrey A. Gilreath et al. Journal of the National Comprehensive Cancer Network
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial
- (2013) Yves Beguin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
- (2013) H. Ludwig et al. ANNALS OF ONCOLOGY
- Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy
- (2013) Punnada Athibovonsuk et al. GYNECOLOGIC ONCOLOGY
- Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study
- (2013) Hikmat Abdel-Razeq et al. Drug Design Development and Therapy
- Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials
- (2012) Anat Gafter-Gvili et al. ACTA ONCOLOGICA
- Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
- (2012) T. Steinmetz et al. ANNALS OF ONCOLOGY
- Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- Iron sensing and signalling
- (2011) Rayko Evstatiev et al. GUT
- Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials
- (2011) Fausto Petrelli et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective
- (2011) Elisabeth Luporsi et al. JOURNAL OF MEDICAL ECONOMICS
- Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia
- (2010) Michael Auerbach et al. AMERICAN JOURNAL OF HEMATOLOGY
- Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
- (2010) D. Schrijvers et al. ANNALS OF ONCOLOGY
- American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
- (2010) J. D. Rizzo et al. BLOOD
- Detection, evaluation, and management of iron-restricted erythropoiesis
- (2010) L. T. Goodnough et al. BLOOD
- Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis
- (2010) Jonathan Eckard et al. Cancer Cell International
- Two to Tango: Regulation of Mammalian Iron Metabolism
- (2010) Matthias W. Hentze et al. CELL
- Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy
- (2010) Penkae Dangsuwan et al. GYNECOLOGIC ONCOLOGY
- Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia
- (2010) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- GERD and insomnia—first degree relatives or distant cousins?
- (2010) Ellen Stein et al. Nature Reviews Gastroenterology & Hepatology
- A new concept for the differential diagnosis and therapy of anaemia in cancer patients
- (2010) H. Tilman Steinmetz et al. SUPPORTIVE CARE IN CANCER
- Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
- (2009) E. C. Vamvakas et al. BLOOD
- Ferric Carboxymaltose
- (2009) Katherine A. Lyseng-Williamson et al. DRUGS
- Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study
- (2009) Heinz Ludwig et al. EUROPEAN JOURNAL OF CANCER
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature*
- (2008) Paul E. Marik et al. CRITICAL CARE MEDICINE
- The silent risks of blood transfusion
- (2008) James Rawn Current Opinion in Anesthesiology
- Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia
- (2008) Laurent Bastit et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa
- (2008) Paolo Pedrazzoli et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now